<DOC>
	<DOCNO>NCT02283632</DOCNO>
	<brief_summary>This single site trial assess metabolic effect subject Jejunal Diversion procedure perform .</brief_summary>
	<brief_title>A Trial Jejunal Diversion Procedure</brief_title>
	<detailed_description>The Jejunal Diversion procedure adaptation jejuno-jejunostomy , surgical procedure often use address mix pathological condition . The safety Jejunal Diversion procedure question , rather understanding gastrointestinal signalling effect . Up 25 eligible subject enrol trial . Enrollment stop 15 subject undergone Jejunal Diversion procedure</detailed_description>
	<criteria>1 . 20 60 year age ( inclusive ) date ICD sign 2 . A BMI ≥ 27 kg/m2 &lt; 40 kg/m2 3 . HbA1c ≥ 8 % ( 63.9 mmol/mol ) ≤ 11 % ( 96.7 mmol/mol ) 4 . Cpeptide ≥ 3 ng/mL ( 0.999 nmol/L ) 5 . At least one following : 1 . Systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg , antihypertensive medication 2 . HDL &lt; 40 mg/dL ( 1.0344 mmol/L ) ( men ) &lt; 50 mg/dL ( 1.293 mmol/L ) ( woman ) , medication low HDL 3 . LDL &gt; 100 mg/dL ( 2.586 mmol/L ) , medication high LDL 4 . TG ≥ 150 mg/dL ( 1.694 mmol/L ) TG lower medication treatment 5 . FPG ≥ 100 mg/dL ( 5.556 mmol/L ) medication hyperglycemia antiT2DM 6 . Able comprehend sign ECapproved trial ICD 1 . Unable unwilling attend followup visit examination 2 . History drug and/or alcohol abuse within 2 year Screening Visit 3 . Any previous major GI surgery ( e.g. , GI surgery resection , etc . ) Examples previous GI surgery allow include : appendectomy , gall bladder surgery , liver biopsy , endoscopic procedure , etc . 4 . Scheduled concurrent surgical procedure 5 . Women childbearing potential pregnant lactating time screen , time surgery , plan become pregnant followup period 6 . Psychiatric disorder may affect compliance clinical trial , include dementia , active psychosis , severe depression , history suicide attempt 7 . Any condition precludes compliance trial , include : 1 . Inflammatory disease GI tract , include severe intractable esophagitis , gastric ulceration , duodenal ulceration , specific inflammation Crohn 's disease ulcerative colitis active within past 10 year 2 . History Hepatitis B C 3 . T1DM 4 . LADA ( confirm positive GAD autoantibody , IAA , ICA ) 5 . Immunocompromised result chronic oral steroid use , cancer chemotherapeutic agent , immune deficiency disorder 8 . Screening laboratory test follow : 1 . ALT and/or AST level ≥ 4 time ULN accord laboratory normal range 2 . Blood creatinine level ≥ 1.5 time ULN accord laboratory normal range 3 . BUN level ≥ 1.5 time ULN accord laboratory normal range 9 . Use follow medication past 120 day : 1 . Chronic steroid use 2 . Prescription overthecounter medication supplement primary indication know cause assist weight reduction 10 . Use follow medication past 60 day : a. Promotility agents 11 . Any medical condition finding , discretion PI , subject exclude 12 . Participation clinical trial ( include registry surveyonly study ) within 30 day 5 half life investigational drug ( ever longer ) , Visit 1 ( Screening Visit ) duration trial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>